Page last updated: 2024-08-22

diallyl disulfide and Parkinson Disease

diallyl disulfide has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, L; Dey, J; Moore, K; Muchowski, PJ; Pallanck, LJ; Trinh, K; Wes, PD1

Other Studies

1 other study(ies) available for diallyl disulfide and Parkinson Disease

ArticleYear
Induction of the phase II detoxification pathway suppresses neuron loss in Drosophila models of Parkinson's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2008, Jan-09, Volume: 28, Issue:2

    Topics: Age Factors; Allyl Compounds; alpha-Synuclein; Animals; Animals, Genetically Modified; Cell Death; Disease Models, Animal; Disulfides; Dose-Response Relationship, Drug; Drosophila; Drosophila Proteins; Glutathione; Isothiocyanates; Metabolic Detoxication, Phase II; Metabolic Networks and Pathways; Mutation; Nerve Degeneration; Nerve Tissue Proteins; Neurons; Parkinson Disease; Sulfoxides; Thiocyanates; Tyrosine 3-Monooxygenase

2008